Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
5th February 2021 | Holdings Ii L.P. Blackstone | 1,282,927 | Conversion of derivative | $0.00 | |
5th February 2021 | Holdings Ii L.P. Blackstone | 29,933 | Conversion of derivative | $0.00 | |
5th February 2021 | Freeze Parent L.P. Blackstone | 29,933 | Conversion of derivative | $0.00 | |
5th February 2021 | Freeze Parent L.P. Blackstone | 1,282,927 | Conversion of derivative | $0.00 | |
31st December 2020 | Daniel M Hancock | 261 | Grant/award etc. | $44.11 | $11,512.71 |
31st December 2020 | Edward J Zecchini | 208 | Grant/award etc. | $44.11 | $9,174.88 |
30th December 2020 | Holdings Ii L.P. Blackstone | 19,011 | Other acquisition or disposition | $0.00 | |
30th December 2020 | Holdings Ii L.P. Blackstone | 46,101 | Open or private purchase | $34.14 | $1,573,888.14 |
30th December 2020 | Holdings Ii L.P. Blackstone | 54,348 | Other acquisition or disposition | $0.00 | |
30th December 2020 | Holdings Ii L.P. Blackstone | 27,258 | Open or private purchase | $33.71 | $918,867.18 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
3rd December 2020